SAPHYR Trial: Sarilumab Wins in Relapsing Polymyalgia Rheumatica NEJM reported today that #PMR patients who fail to re
Tweet Content
SAPHYR Trial: Sarilumab Wins in Relapsing Polymyalgia Rheumatica
NEJM reported today that #PMR patients who fail to respond to standard doses of prednisone therapy, were significantly better when given the IL-6 inhibitor sarilumab (than placebo).
https://t.co/k5SAshxdsg https://t.co/tMtRHn2C6j
Links
SAPHYR Trial: Sarilumab Wins in Relapsing Polymyalgia Rheumatica | RheumNow
https://bit.ly/3M0MZ7o
Show on Archive Page
On
Display in Search Results
On
PDQ
Off